Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 77 | 2023 | 4214 | 2.080 |
Why?
|
Graft Survival | 52 | 2021 | 3794 | 1.470 |
Why?
|
HLA Antigens | 25 | 2023 | 1368 | 1.260 |
Why?
|
Graft Rejection | 58 | 2021 | 4427 | 1.180 |
Why?
|
Histocompatibility Testing | 25 | 2023 | 717 | 1.140 |
Why?
|
Tissue Donors | 34 | 2023 | 2311 | 0.870 |
Why?
|
Isoantibodies | 8 | 2023 | 661 | 0.670 |
Why?
|
HLA-DR Antigens | 14 | 2022 | 630 | 0.600 |
Why?
|
Vacuolar Proton-Translocating ATPases | 6 | 2014 | 196 | 0.550 |
Why?
|
Antibodies | 10 | 2017 | 2420 | 0.470 |
Why?
|
Living Donors | 5 | 2023 | 638 | 0.440 |
Why?
|
Antibodies, Monoclonal | 45 | 2014 | 9163 | 0.430 |
Why?
|
Histocompatibility | 5 | 2018 | 316 | 0.430 |
Why?
|
Histocompatibility Antigens Class I | 11 | 2023 | 1354 | 0.400 |
Why?
|
Kidney Failure, Chronic | 14 | 2018 | 2455 | 0.400 |
Why?
|
Receptors, Interleukin-2 | 19 | 2005 | 562 | 0.370 |
Why?
|
HLA-B Antigens | 9 | 2000 | 331 | 0.370 |
Why?
|
Lymphocytes | 11 | 2008 | 2610 | 0.340 |
Why?
|
Antilymphocyte Serum | 5 | 2015 | 482 | 0.330 |
Why?
|
Tissue and Organ Procurement | 9 | 2011 | 943 | 0.320 |
Why?
|
Facial Transplantation | 3 | 2016 | 221 | 0.310 |
Why?
|
Immunosuppressive Agents | 12 | 2016 | 4159 | 0.290 |
Why?
|
Lung Transplantation | 4 | 2017 | 1306 | 0.280 |
Why?
|
T-Lymphocytes | 26 | 2020 | 10167 | 0.280 |
Why?
|
Lymphocyte Activation | 17 | 2022 | 5489 | 0.270 |
Why?
|
Heart Transplantation | 19 | 2013 | 3220 | 0.270 |
Why?
|
Organ Transplantation | 7 | 2018 | 1150 | 0.270 |
Why?
|
Blood Donors | 3 | 2011 | 343 | 0.270 |
Why?
|
Cyclosporins | 14 | 1999 | 216 | 0.250 |
Why?
|
HLA-A Antigens | 5 | 2000 | 225 | 0.240 |
Why?
|
Blood Group Incompatibility | 3 | 2023 | 135 | 0.240 |
Why?
|
Histocompatibility Antigens | 9 | 1991 | 466 | 0.240 |
Why?
|
Renal Dialysis | 6 | 2008 | 1786 | 0.230 |
Why?
|
Mycophenolic Acid | 3 | 2015 | 343 | 0.220 |
Why?
|
Steroids | 2 | 2015 | 926 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 13 | 2022 | 3069 | 0.190 |
Why?
|
Transplantation, Homologous | 25 | 2014 | 4808 | 0.190 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2020 | 5648 | 0.190 |
Why?
|
Angiotensins | 1 | 2001 | 143 | 0.180 |
Why?
|
Flow Cytometry | 16 | 2015 | 5861 | 0.170 |
Why?
|
Lymphocyte Culture Test, Mixed | 15 | 1993 | 516 | 0.170 |
Why?
|
Calcium Channel Blockers | 1 | 2003 | 694 | 0.170 |
Why?
|
Rats, Inbred Lew | 25 | 1999 | 1154 | 0.170 |
Why?
|
Polymorphism, Genetic | 6 | 2007 | 4282 | 0.170 |
Why?
|
Immunoglobulin G | 6 | 2008 | 4540 | 0.170 |
Why?
|
Phosphates | 1 | 2003 | 771 | 0.160 |
Why?
|
Antibody Specificity | 6 | 2011 | 1060 | 0.160 |
Why?
|
Cold Ischemia | 1 | 2018 | 67 | 0.150 |
Why?
|
Interleukin-2 | 12 | 2005 | 1890 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 9 | 2014 | 1351 | 0.140 |
Why?
|
Humans | 146 | 2023 | 757566 | 0.140 |
Why?
|
Graft vs Host Disease | 7 | 2020 | 3024 | 0.140 |
Why?
|
Antigens, Surface | 6 | 2005 | 1607 | 0.140 |
Why?
|
Bone Marrow Transplantation | 5 | 2011 | 2691 | 0.140 |
Why?
|
Age Factors | 9 | 2021 | 18326 | 0.130 |
Why?
|
Hematologic Neoplasms | 3 | 2015 | 1890 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2022 | 1173 | 0.130 |
Why?
|
Transplantation Conditioning | 4 | 2014 | 1588 | 0.130 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2016 | 81 | 0.130 |
Why?
|
Resource Allocation | 1 | 1998 | 349 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 5 | 2003 | 1445 | 0.130 |
Why?
|
OX40 Ligand | 1 | 2015 | 55 | 0.130 |
Why?
|
Rats, Inbred BN | 15 | 1999 | 231 | 0.130 |
Why?
|
Kidney | 16 | 2019 | 7012 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2003 | 1033 | 0.120 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 372 | 0.120 |
Why?
|
Policy Making | 1 | 1998 | 538 | 0.120 |
Why?
|
Middle Aged | 52 | 2018 | 219192 | 0.120 |
Why?
|
Homozygote | 2 | 2015 | 1788 | 0.120 |
Why?
|
Haplotypes | 7 | 2010 | 2764 | 0.120 |
Why?
|
Fluorocarbons | 1 | 2019 | 489 | 0.110 |
Why?
|
Multivariate Analysis | 7 | 2011 | 12047 | 0.110 |
Why?
|
Cadaver | 14 | 2004 | 1345 | 0.110 |
Why?
|
Hypertension | 4 | 2003 | 8502 | 0.110 |
Why?
|
Male | 85 | 2021 | 358180 | 0.110 |
Why?
|
Survival Analysis | 12 | 2017 | 10075 | 0.110 |
Why?
|
Protein Subunits | 3 | 2005 | 942 | 0.110 |
Why?
|
Adult | 56 | 2020 | 219725 | 0.110 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 321 | 0.110 |
Why?
|
Aging | 2 | 2011 | 8654 | 0.110 |
Why?
|
Inflammation | 3 | 2008 | 10709 | 0.110 |
Why?
|
Body Mass Index | 1 | 2011 | 12868 | 0.110 |
Why?
|
Gene Frequency | 3 | 1997 | 3612 | 0.110 |
Why?
|
Azathioprine | 8 | 1991 | 356 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1610 | 0.100 |
Why?
|
Aged | 32 | 2021 | 167890 | 0.100 |
Why?
|
Complement System Proteins | 2 | 2014 | 782 | 0.100 |
Why?
|
Female | 67 | 2021 | 389943 | 0.100 |
Why?
|
Proportional Hazards Models | 6 | 2011 | 12397 | 0.100 |
Why?
|
Kidney Diseases | 3 | 2001 | 2082 | 0.100 |
Why?
|
Immunologic Factors | 2 | 2014 | 1584 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1088 | 0.100 |
Why?
|
Statistical Distributions | 2 | 2002 | 63 | 0.100 |
Why?
|
Transplantation Chimera | 1 | 2014 | 594 | 0.100 |
Why?
|
Time Factors | 26 | 2018 | 39811 | 0.090 |
Why?
|
Information Theory | 2 | 2002 | 49 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1487 | 0.090 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 557 | 0.090 |
Why?
|
Rats | 35 | 2000 | 23676 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2018 | 64242 | 0.090 |
Why?
|
Antigens, CD | 6 | 2015 | 3996 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3415 | 0.090 |
Why?
|
Immunocompetence | 1 | 2010 | 138 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 931 | 0.090 |
Why?
|
Tacrolimus | 3 | 2015 | 733 | 0.090 |
Why?
|
Risk Assessment | 5 | 2018 | 23816 | 0.090 |
Why?
|
Apolipoproteins | 1 | 2012 | 319 | 0.090 |
Why?
|
Calcium | 1 | 2003 | 5720 | 0.080 |
Why?
|
Receptors, CCR5 | 2 | 2010 | 486 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2008 | 4350 | 0.080 |
Why?
|
BK Virus | 1 | 2010 | 123 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 1992 | 899 | 0.080 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2011 | 305 | 0.080 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 534 | 0.080 |
Why?
|
Waiting Lists | 7 | 2000 | 761 | 0.080 |
Why?
|
Th1 Cells | 1 | 2014 | 1031 | 0.080 |
Why?
|
HLA-DR2 Antigen | 1 | 2008 | 47 | 0.080 |
Why?
|
Lymphocyte Depletion | 3 | 2004 | 602 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2014 | 6470 | 0.080 |
Why?
|
Fluoroquinolones | 1 | 2010 | 308 | 0.080 |
Why?
|
Polyomavirus Infections | 1 | 2010 | 194 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2003 | 3603 | 0.070 |
Why?
|
Lipoproteins, HDL | 1 | 2012 | 664 | 0.070 |
Why?
|
Alleles | 7 | 2023 | 6894 | 0.070 |
Why?
|
Th17 Cells | 1 | 2014 | 785 | 0.070 |
Why?
|
Patient Selection | 2 | 1999 | 4235 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1908 | 0.070 |
Why?
|
Integrin beta3 | 1 | 2007 | 120 | 0.070 |
Why?
|
Animals | 53 | 2021 | 167718 | 0.070 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 1987 | 105 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1356 | 0.070 |
Why?
|
Monocytes | 4 | 2008 | 2568 | 0.070 |
Why?
|
Tissue Banks | 4 | 1993 | 184 | 0.070 |
Why?
|
Skin | 1 | 2020 | 4464 | 0.070 |
Why?
|
Antigens | 5 | 2023 | 1445 | 0.070 |
Why?
|
Hepatitis Antibodies | 4 | 1993 | 68 | 0.070 |
Why?
|
HLA-C Antigens | 1 | 2006 | 147 | 0.060 |
Why?
|
Rats, Inbred Strains | 10 | 1992 | 2090 | 0.060 |
Why?
|
Cohort Studies | 9 | 2018 | 41190 | 0.060 |
Why?
|
Rats, Inbred WF | 10 | 1998 | 138 | 0.060 |
Why?
|
Receptors, Fc | 3 | 2008 | 535 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 4 | 1989 | 972 | 0.060 |
Why?
|
New England | 6 | 2004 | 1051 | 0.060 |
Why?
|
Endothelium, Vascular | 4 | 2003 | 4427 | 0.060 |
Why?
|
ABO Blood-Group System | 2 | 2023 | 367 | 0.060 |
Why?
|
Adolescent | 19 | 2015 | 87819 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2005 | 183 | 0.060 |
Why?
|
HLA-D Antigens | 1 | 2004 | 134 | 0.060 |
Why?
|
Risk Factors | 14 | 2017 | 73708 | 0.060 |
Why?
|
Antigens, Differentiation | 3 | 2001 | 910 | 0.060 |
Why?
|
Transplantation Immunology | 3 | 1993 | 532 | 0.060 |
Why?
|
Preoperative Care | 2 | 2014 | 2246 | 0.060 |
Why?
|
Angiotensin II | 1 | 2007 | 848 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 4 | 2007 | 3753 | 0.060 |
Why?
|
Antibody Formation | 7 | 1993 | 1397 | 0.060 |
Why?
|
Body Constitution | 1 | 2004 | 273 | 0.060 |
Why?
|
Cross Reactions | 5 | 2016 | 818 | 0.060 |
Why?
|
United States | 10 | 2018 | 71902 | 0.050 |
Why?
|
Registries | 6 | 2018 | 8164 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2237 | 0.050 |
Why?
|
Hemodialysis Solutions | 1 | 2002 | 7 | 0.050 |
Why?
|
Acute Disease | 8 | 2007 | 7225 | 0.050 |
Why?
|
Antigen-Presenting Cells | 3 | 2020 | 963 | 0.050 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2004 | 263 | 0.050 |
Why?
|
Genes, MHC Class I | 1 | 2003 | 240 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1254 | 0.050 |
Why?
|
Postoperative Complications | 5 | 2004 | 15532 | 0.050 |
Why?
|
Rabbits | 5 | 2004 | 4772 | 0.050 |
Why?
|
Renin-Angiotensin System | 1 | 2007 | 733 | 0.050 |
Why?
|
Multiple Sclerosis | 3 | 2014 | 3202 | 0.050 |
Why?
|
Hepatitis C | 4 | 1993 | 1579 | 0.050 |
Why?
|
Hemoglobins | 1 | 2008 | 1518 | 0.050 |
Why?
|
Signal Transduction | 7 | 2008 | 23335 | 0.050 |
Why?
|
Major Histocompatibility Complex | 5 | 2006 | 927 | 0.050 |
Why?
|
Cell Proliferation | 4 | 2014 | 10405 | 0.050 |
Why?
|
Cytokines | 3 | 2014 | 7336 | 0.050 |
Why?
|
DNA, Complementary | 3 | 1999 | 1992 | 0.050 |
Why?
|
Milk Proteins | 1 | 2002 | 163 | 0.050 |
Why?
|
B-Lymphocytes | 6 | 2015 | 4737 | 0.050 |
Why?
|
Membranes, Artificial | 1 | 2002 | 365 | 0.050 |
Why?
|
Transplantation, Heterologous | 3 | 2015 | 2378 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7366 | 0.050 |
Why?
|
Hematologic Diseases | 1 | 2004 | 496 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 243 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2014 | 664 | 0.040 |
Why?
|
Isoantigens | 2 | 1981 | 552 | 0.040 |
Why?
|
Cell Death | 1 | 2005 | 1666 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2003 | 2159 | 0.040 |
Why?
|
Genotype | 5 | 2023 | 12951 | 0.040 |
Why?
|
Diuretics | 1 | 2003 | 610 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2003 | 294 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2005 | 15207 | 0.040 |
Why?
|
Retrospective Studies | 12 | 2017 | 79984 | 0.040 |
Why?
|
Fetal Blood | 2 | 2011 | 1342 | 0.040 |
Why?
|
Nocardia asteroides | 1 | 1999 | 9 | 0.040 |
Why?
|
Cyclosporine | 2 | 2000 | 777 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 2016 | 303 | 0.040 |
Why?
|
Cytomegalovirus Infections | 4 | 1991 | 831 | 0.040 |
Why?
|
Nocardia Infections | 1 | 1999 | 19 | 0.040 |
Why?
|
Child, Preschool | 10 | 2015 | 42045 | 0.040 |
Why?
|
Sarcoma, Kaposi | 1 | 2002 | 374 | 0.040 |
Why?
|
Egg Proteins | 1 | 1999 | 57 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2015 | 22022 | 0.040 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6807 | 0.040 |
Why?
|
Membrane Proteins | 4 | 2002 | 7840 | 0.040 |
Why?
|
Retreatment | 1 | 2000 | 596 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 653 | 0.040 |
Why?
|
Human Body | 1 | 1998 | 37 | 0.040 |
Why?
|
Health Services Accessibility | 2 | 2011 | 5382 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 3799 | 0.040 |
Why?
|
Antibodies, Anti-Idiotypic | 5 | 1992 | 357 | 0.040 |
Why?
|
Minority Groups | 2 | 2010 | 1199 | 0.040 |
Why?
|
Immunity, Cellular | 3 | 2014 | 1557 | 0.040 |
Why?
|
Brain Abscess | 1 | 1999 | 120 | 0.040 |
Why?
|
Infant | 9 | 2015 | 36045 | 0.040 |
Why?
|
Anemia | 1 | 2008 | 1503 | 0.040 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2002 | 321 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2017 | 25924 | 0.040 |
Why?
|
Rats, Inbred F344 | 6 | 2000 | 825 | 0.040 |
Why?
|
Renal Insufficiency | 1 | 2004 | 809 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1999 | 410 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 401 | 0.040 |
Why?
|
Immunization, Passive | 3 | 1991 | 616 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2200 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2011 | 14473 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 3055 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 377 | 0.040 |
Why?
|
Saliva | 1 | 2002 | 820 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 1598 | 0.040 |
Why?
|
Child | 13 | 2015 | 79782 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2003 | 1240 | 0.040 |
Why?
|
Epitopes | 7 | 1991 | 2502 | 0.040 |
Why?
|
Body Surface Area | 1 | 1997 | 197 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2267 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2002 | 558 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 1999 | 819 | 0.040 |
Why?
|
Brain Death | 1 | 2000 | 356 | 0.030 |
Why?
|
Organ Specificity | 1 | 2001 | 1955 | 0.030 |
Why?
|
Vietnam | 1 | 2017 | 409 | 0.030 |
Why?
|
Interferon-gamma | 2 | 2020 | 3154 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2008 | 5095 | 0.030 |
Why?
|
Federal Government | 1 | 1998 | 267 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2016 | 79 | 0.030 |
Why?
|
Immunophenotyping | 3 | 2015 | 1870 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3152 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 1503 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 787 | 0.030 |
Why?
|
Plasmapheresis | 2 | 2014 | 206 | 0.030 |
Why?
|
Macaca fascicularis | 5 | 1989 | 900 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1824 | 0.030 |
Why?
|
Young Adult | 7 | 2018 | 58755 | 0.030 |
Why?
|
Mice | 10 | 2021 | 81066 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2531 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2007 | 1130 | 0.030 |
Why?
|
Chronic Disease | 4 | 2017 | 9263 | 0.030 |
Why?
|
Oncogene Proteins v-myb | 1 | 2015 | 25 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18114 | 0.030 |
Why?
|
Databases as Topic | 1 | 1997 | 472 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5781 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2625 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2006 | 1627 | 0.030 |
Why?
|
Colonic Diseases | 1 | 1997 | 201 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 800 | 0.030 |
Why?
|
Intestine, Small | 2 | 1991 | 1205 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4220 | 0.030 |
Why?
|
Probability | 1 | 2000 | 2462 | 0.030 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 1997 | 249 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2001 | 1736 | 0.030 |
Why?
|
HLA-DQ Antigens | 2 | 1993 | 211 | 0.030 |
Why?
|
Indians, North American | 2 | 1996 | 350 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1477 | 0.030 |
Why?
|
Apoptosis | 2 | 2008 | 9466 | 0.030 |
Why?
|
Cells, Cultured | 8 | 2014 | 18936 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2020 | 907 | 0.030 |
Why?
|
Liver Diseases | 2 | 1993 | 1296 | 0.030 |
Why?
|
Immune Tolerance | 3 | 1993 | 2295 | 0.030 |
Why?
|
Clinical Trials as Topic | 6 | 2003 | 7982 | 0.030 |
Why?
|
Government Regulation | 1 | 1998 | 524 | 0.030 |
Why?
|
Estradiol | 1 | 2021 | 1933 | 0.030 |
Why?
|
North America | 1 | 1997 | 1273 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2001 | 949 | 0.030 |
Why?
|
Prognosis | 5 | 2016 | 29488 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2004 | 2621 | 0.030 |
Why?
|
DNA Primers | 2 | 1998 | 2816 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 209 | 0.030 |
Why?
|
Demyelinating Diseases | 1 | 1996 | 351 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1989 | 365 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1993 | 416 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2015 | 152 | 0.030 |
Why?
|
Boston | 4 | 2014 | 9298 | 0.030 |
Why?
|
Postoperative Period | 4 | 2002 | 1806 | 0.030 |
Why?
|
Rats, Inbred ACI | 5 | 1983 | 34 | 0.030 |
Why?
|
Sex Factors | 2 | 2004 | 10495 | 0.030 |
Why?
|
Indians, South American | 1 | 1992 | 34 | 0.030 |
Why?
|
Tissue Transplantation | 1 | 1993 | 128 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4565 | 0.030 |
Why?
|
Cell Separation | 5 | 1990 | 1720 | 0.030 |
Why?
|
Antigens, Heterophile | 1 | 1992 | 70 | 0.020 |
Why?
|
Cell Line | 5 | 2005 | 15587 | 0.020 |
Why?
|
Survival Rate | 4 | 2015 | 12684 | 0.020 |
Why?
|
Gene Expression | 2 | 2001 | 7584 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1994 | 663 | 0.020 |
Why?
|
Prospective Studies | 9 | 2020 | 54092 | 0.020 |
Why?
|
Base Sequence | 6 | 1999 | 12437 | 0.020 |
Why?
|
Molecular Sequence Data | 7 | 1999 | 17615 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Hepacivirus | 3 | 1993 | 1333 | 0.020 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1993 | 251 | 0.020 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1992 | 436 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1785 | 0.020 |
Why?
|
Follow-Up Studies | 6 | 2004 | 39020 | 0.020 |
Why?
|
Premedication | 1 | 1991 | 247 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2004 | 4550 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 1990 | 176 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2003 | 17767 | 0.020 |
Why?
|
Immune Sera | 2 | 1988 | 613 | 0.020 |
Why?
|
Transplantation, Heterotopic | 1 | 1991 | 174 | 0.020 |
Why?
|
Heterozygote | 1 | 1997 | 2797 | 0.020 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 1990 | 20 | 0.020 |
Why?
|
Diabetes Complications | 2 | 1999 | 1317 | 0.020 |
Why?
|
Myelin Proteolipid Protein | 1 | 1990 | 107 | 0.020 |
Why?
|
Biological Evolution | 2 | 1996 | 1072 | 0.020 |
Why?
|
Hybridomas | 2 | 2002 | 442 | 0.020 |
Why?
|
Thymus Gland | 4 | 1993 | 1240 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1003 | 0.020 |
Why?
|
Bone Marrow | 1 | 2000 | 2908 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 1989 | 168 | 0.020 |
Why?
|
Kinetics | 3 | 1989 | 6371 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1997 | 1165 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1999 | 1698 | 0.020 |
Why?
|
Computational Biology | 1 | 2001 | 3501 | 0.020 |
Why?
|
Fluorescent Dyes | 2 | 2005 | 1897 | 0.020 |
Why?
|
Risk | 4 | 2006 | 9590 | 0.020 |
Why?
|
Urban Population | 1 | 1997 | 2023 | 0.020 |
Why?
|
Creatinine | 3 | 1999 | 1892 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 227 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8512 | 0.020 |
Why?
|
Blood Pressure | 2 | 2001 | 8453 | 0.020 |
Why?
|
Immunization | 2 | 1992 | 1226 | 0.020 |
Why?
|
Immunoglobulins | 2 | 1988 | 859 | 0.020 |
Why?
|
Communicable Diseases | 2 | 2014 | 876 | 0.020 |
Why?
|
Recurrence | 2 | 2014 | 8426 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2008 | 109 | 0.020 |
Why?
|
Rats, Inbred BUF | 4 | 1982 | 19 | 0.020 |
Why?
|
Phenotype | 4 | 1997 | 16533 | 0.020 |
Why?
|
Organ Size | 1 | 1993 | 2248 | 0.020 |
Why?
|
Incidence | 3 | 2002 | 21217 | 0.020 |
Why?
|
|